Warning: Cannot modify header information - headers already sent by (output started at /home/webadmin/mesorc.com/html/diagnosis/mesothelioma-ongoing-clinical-trials-phase-0.php:1) in /home/webadmin/mesorc.com/html/includes/layout/subdomain-cookies.php on line 15
Mesothelioma Resource Center: Mesothelioma Ongoing Clinical Trials - No Phase Specified

Mesothelioma Ongoing Clinical Trials - No Phase Specified


Correlation of x-Ray and Pathology with Needle Biopsy of Lung Tumors

No Phase Specified

Location:

SUNY Upstate Medical University Hospital

Trial Summary:

We want to compare the features that the pathologist sees, when examining a lung tumor under the microscope, to the way that the tumor appears on the CT scan. Features of the tumor may include abnormal blood vessels and areas in which tumor cells are dying. The samples that are taken during the needle biopsy contain information from one small part of the tumor. We believe that we can show where in the tumor the samples came from, based on the CT scans during the biopsy procedure.

Contact Information:
Ernest Scalzetti, MD: Principal Investigator
Susan Hemingway, CCRP:
Ph: 315-464-5099
Email: hemingws@upstate.edu

For Additional Information,  Click Here


Improving Functional Outcomes in Patients with Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging

No Phase Specified

Location:

New York, NY: Memorial Sloan-Kettering Cancer Center

Trial Summary:

The purpose of this study is to see how the brain re-learns to control the larynx in speaking and swallowing when undergoing surgical rehabilitation in the form of either thyroplasty or vocal fold augmentation for unilateral vocal cord paralysis. What is needed is information on how the brain re-learns to control speaking and swallowing so that we can eventually learn how to help patients re-learn faster after their procedure. Functional Magnetic Resonance Imaging (or fMRI) will allow us to image your brain as you speak and swallow. We will produce "brain maps" for speaking, swallowing and hand movements.

Contact Information:
Dennis H. Kraus MD: Principal Investigator
Email: krausd@mskcc.org

Ryan Branski, PhD:
Email: branskir@mskcc.org

For Additional Information,  Click Here


The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning

No Phase Specified

Location:

New York, NY: Memorial Sloan-Kettering Cancer Center

Trial Summary:

The purpose of this study is to find out whether a new device can help obtain more accurate CT and PET scans of the lungs and chest tumors and the liver and liver tumors to help in delivering radiation therapy. When we breathe, the amount of air in the lung changes. Lung tumors may also move during breathing. Liver tumors may also move with breathing; as the lungs inflate, the liver can be pushed down. A CT scan (a special type of X-ray) is routinely obtained as part of planning for lung or liver radiation therapy.

Contact Information:
Kenneth Rosenzweig, MD Principal Investigator:
Email rosenzwk@mskcc.org

For Additional Information,  Click Here


Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot Study

No Phase Specified

Location:

Madison, WI: University of Wisconsin Paul P. Carbone Comprehensive Cancer Center

Trial Summary:

The overall, broad objective of this study is to pilot the BSD technique. The specific purpose of this particular study is to generate pilot data to validate several crucial steps of the BSD technique, in particular steps 1, 2, and 4. Radiation treatments will proceed per standard of care, and will not be modified in any way during this protocol. This study is a non-treatment protocol.

Contact Information:
Minesh Mehta Principal Investigator Cancer Connect
Ph: 608-622-8922

For Additional Information,  Click Here


Study of Previously Collected and Stored Tissue Samples from Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

No Phase Specified

Location:

Bethesda, MD: NCI - Center for Cancer Research

Trial Summary:

Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. This laboratory study is looking at previously collected and stored tissue samples from patients previously enrolled in a completed National Cancer Institute clinical trial.

Contact Information:
Robert Kreitman, MD, Principal investigator:
Ph: 301-496-6947
Email: kreitmar@mail.nih.gov

For Additional Information,  Click Here


Vibration Response Imaging (VRI) in Lung Cancer Patients

No Phase Specified

Location:

Houston, TX: M. D. Anderson Cancer Center at University of Texas

Trial Summary:

Primary Objective: To estimate the accuracy of the pre-operative VRI Quantitative Regional Function results versus the gold standard Quantitative Radionuclide Study of Regional Lung Ventilation and Perfusion pre-operative scan.

Contact Information:
Rodolfo C. Morice, MD Principal Investigator:
Ph: 713-792-6238

For Additional Information,  Click Here


Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

No Phase Specified

Location:

Detroit, MI: Barbara Ann Karmanos Cancer Institute

Trial Summary:

Studying samples of body fluid and blood from patients who have been exposed to asbestos or vermiculite in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

Contact Information:
Anil Wali, PhD, Protocol chair:
Ph: 313-576-8302; 800-527-6266
Email: walia@karmanos.org

Clinical Trials Office
Ph: 313-576-9363

For Additional Information,  Click Here


Multiple Biomarkers in Undiagnosed Pleural Effusion

No Phase Specified

Location:

Malvern, PA: Fujirebio Diagnostics, Incorporated

Trial Summary:

The purpose of this clinical trial is to evaluate the ability of various biomarkers measured in serum and/or pleural fluids to estimate the risk of finding cancer in patients with undiagnosed pleural effusions. An algorithm for prediction of the risk of finding cancer in the patient using an optimal combination of markers will be developed, and patients will be categorized as having a low, moderate, or high risk of finding cancer that might be used to more effectively triage patients.

Contact Information:
Jeffrey Allard, PhD Study Director
Harvey I Pass, M.D. Principal Investigator
Elizabeth B Somers, BS:
Ph: 610-240-3812
Email: somerse@fdi.com

Craig Miller, BS:
Ph: 610-240-3828
Email: millerc@fdi.com

For Additional Information,  Click Here


Study of Patients with Non-Small Cell Lung Cancer, Esophageal Cancer, or Malignant Pleural Mesothelioma

No Phase Specified

Location:

Bethesda, MD: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office

Trial Summary:

Collecting and storing samples of tissue, blood, and urine from patients with cancer to study in the laboratory may help the study of cancer. It may also help doctors identify patients who are eligible for clinical trials. This study is collecting and examining tissue, blood, and urine samples from patients with non-small cell lung cancer, esophageal cancer, or malignant pleural mesothelioma.

Contact Information:
David Schrump, MD, Protocol chair:
Ph: 301-496-2127
Email: david_schrump@nih.gov
Clinical Trials Office:
Ph: 888-NCI-1937

For Additional Information,  Click Here


Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers

No Phase Specified

Location:

Toronto, Ontario, Canada: Princess Margaret Hospital

Trial Summary:

Occupational exposure to asbestos is known increase the risk of developing cancer of the lungs (bronchogenic carcinoma) or of the pleura (mesothelioma). Symptoms are subtle and non-specific, diagnosis is often late and the prognosis consequently is dismal. Currently there is no accepted non-invasive tool for the early diagnosis of mesothelioma or lung cancer in asbestos-exposed subjects. In the last decade, low-dose computed tomography (LDCT) has been successfully developed and validated for the early diagnosis of lung cancer in high-risk smokers. Malignant mesothelioma might, in an early stage, resemble a benign pleural plaque, which is a common finding after asbestos exposure.

Contact Information:
Demetris Patsios, MD Principal Investigator:
Ph: 416-603-5800 Ext.2583
Email: demetris.patsios@uhn.on.ca

Michael Johnston, MD Principal Investigator

Brenda O'Sullivan:
Ph: 416-340-4800 Ext.5686
Email: Brenda.O'Sullivan@uhn.on.ca

For Additional Information,  Click Here


«  Return to Mesothelioma Ongoing Clinical Trials

  • Text Size:

Read the Meso RC Blog

Read our blog

Join the Meso RC Discussion Board

Find out more

Listen to the Meso RC Podcast

Download the Podcast

MesoRC Featured Articles

Read Our Articles

Contact Our
Social Worker

Send us an email

Request Legal Consultation

2008 WebAward Winner

Click here to view the Press Release
Health Care - Standard of Excellence